1/2ページ
ダウンロード(324.9Kb)
このカタログについて
ドキュメント名 | 「Coronavirus References using ForteBio Octet Systems」 |
---|---|
ドキュメント種別 | 事例紹介 |
ファイルサイズ | 324.9Kb |
取り扱い企業 | ザルトリウス・ジャパン株式会社 (この企業の取り扱いカタログ一覧) |
この企業の関連カタログ
このカタログの内容
Page1
Coronavirus References
ForteBio Octet Systems
1. Daniel Wrapp et al.
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
Science. 2020 Mar; 367(6483): 1260-1263. doi: 10.1126/science.abb2507.
2. Xiaolong Tian et al.
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
Emerging Microbes & Infections. 2020 Dec; 9(1): 382-385. doi: 10.1080/22221751.2020.1729069.
3. Li Y et al.
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
Cell Res. 2015 Nov; 25(11): 1237-49. doi: 10.1038/cr.2015.113.
4. Ha V. Dang et al.
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
Nature Structural & Molecular Biology. 2019 Oct; 26(10): 980-987. doi: 10.1038/s41594-019-0308-9.
5. Y. Cai.
Effects of Active Site Inhibitors on APN-dependent Coronavirus Entry.
Thesis. 2017 June.
6. Lingshu Wang et al.
Evaluation of candidate vaccine approaches for MERS-CoV.
Nature Communications. 2015 Jul 28; 6: 7712. doi: 10.1038/ncomms8712.
7. Yaping Sun et al.
Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
Viruses. 2017 Sep 14; 9(9). pii: E255. doi: 10.3390/v9090255.
8. Wang L et al.
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory
Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
Journal of Virology. 2018 Apr 27; 92(10). pii: e02002-17. doi: 10.1128/JVI.02002-17.
9. de Wispelaere M et al.
Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
Cell Chemical Biology. 2018 Aug; 25(8), 1006-1016.e8. doi: 10.1016/j.chembiol.2018.05.011.
10. Haixia Zhou et al.
Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Nature
Communications. 2019; 10(3068). doi: 10.1038/s41467-019-10897-4.
11. Peihua Niu et al.
Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome
Coronavirus From a Recovered Patient.
The Journal of Infectious Diseases. 2018 Oct; 15218(8): 1249-1260. doi: 10.1093/infdis/jiy311.
12. Walls AC et al.
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.
Cell. 2019 Feb 21; 176(5): 1026-1039.e15. doi: 10.1016/j.cell.2018.12.028.
Page2
13. Xian-Chun Tang et al.
Identification of human neutralizing antibodies against MERS_CoV and their role in virus adaptive evolution.
Proc Natl Acad Sci U S A. 2014 May 13; 111(19): E2018-26. doi: 10.1073/pnas.1402074111.
14. M. Alejandra Tortorici et al.
Structural basis for human coronavirus attachment to sialic acid receptors.
Nature Structural & Molecular Biology volume. 2019 Jun; 26(6): 481–489. doi: 10.1038/s41594-019-0233-y.
15. Chunyun Sun et al.
SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications
on Neutralizing Antibody and Vaccine Development.
doi: 10.1101/2020.02.16.951723. [bioRxiv preprint]
16. Ivy Widjaja et al.
Towards a solution to MERS_protective human mAb targeting different domains and functions of the
MERS-coronavirus spike glycoprotein.
Emerging Microbes & Infections. 2019; 8(1): 516–530. doi: 10.1080/22221751.2019.1597644.
17. Xian-Chun Tang et al.
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.
PNAS. 2014 May 13; 111(19): E2018-E2026. doi: 10.1073/pnas.1402074111.
18. Chunyan Wang et al.
A human monoclonal antibody blocking SARS-CoV-2 infection.
doi: 10.1101/2020.03.11.987958. [bioRxiv preprint]
19. Meng Yuan et al.
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV
Science. 2020 Apr 03. doi: 10.1126/science.abb7269.
20. Alexandra C. Walls et al.
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Cell. 2020 March 09. pii: S0092-8674(20)30262-2. doi: 10.1016/j.cell.2020.02.058. [Epub ahead of print]
21. M. Gordon Joyce et al.
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein.
doi: 10.1101/2020.03.15.992883. [bioRxiv preprint]
22. G. Zhang et al.
The first-in-class peptide binder to the SARS-CoV-2 spike protein.
doi: 10.1101/2020.03.19.999318. [bioRxiv preprint]
23. V.Stalin Raj et al.
Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection.
Science Advances. 2018 Aug 8; 4(8): eaas9667. doi: 10.1126/sciadv.aas9667.
24. Wahiba Aouadi et al.
Binding of the Methyl Donor S-Adenosyl-l-Methionine to Middle East Respiratory Syndrome Coronavirus
2'-O-Methyltransferase nsp16 Promotes Recruitment of the Allosteric Activator nsp10.
Journal of Virology. 2017 Mar 1; 91(5): e02217-16. doi: 10.1128/JVI.02217-16.
© 2020 Sartorius BioAnalytical Instruments, Inc. All rights reserved. Fortebio and Octet are trademarks of Sartorius AG and/or any of its affiliated
entities. Specifications subject to change without notice. For Research Use Only.
www.fortebio.com FB_4018_J2 Rev D